Cheng Ching-Yao, Wang Hue-Yu, Liou Wen-Shyong, Wu Ming-Ju, Kao Chia-Hung
Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan; School of Pharmacy, China Medical University, Taichung, Taiwan.
Department of Pharmacy, Chi Mei Medical Center, Tainan City, Taiwan; Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan City, Taiwan.
Transplant Proc. 2019 Jun;51(5):1402-1405. doi: 10.1016/j.transproceed.2019.01.138. Epub 2019 May 7.
Several comparison studies have suggested that kidney transplant (KT) could reduce stroke risk in patients with end-stage renal disease (ESRD). To avoid the selection criteria bias of using dialysis patients as control groups, we compared the risk of stroke between KT recipients and comparable propensity score-matched dialysis patients.
We used Taiwan's National Health Insurance Research Database to identify patients with newly diagnosed ESRD between 2000 and 2009. We separated them into 2 groups: a KT group and a non-KT dialysis-only group. To evaluate the stroke outcome, we compared each patient with KT to a patient on dialysis without KT using propensity score matching.
In total, 2735 KT recipients and 10,940 propensity score-matched dialysis patients were identified. The incidence rates of overall stroke were 9.1 and 23.4 per 1000 person-years in KT recipients and non-KT dialysis patients. Compared with the propensity score-matched dialysis patients, the patients who received KT exhibited significantly lower overall stroke risk, hemorrhagic stroke, and ischemic stroke, the adjusted hazard ratios were 0.37 (95% CI, 0.31-0.45), 0.19 (95% CI, 0.12-0.29), and 0.46 (95% CI, 0.37-0.56), respectively (all P < .001).
Through a propensity score-matched cohort, this study confirms that KT is associated with a reduced risk of stroke more than dialysis alone in patients with newly diagnosed ESRD.
多项比较研究表明,肾移植(KT)可降低终末期肾病(ESRD)患者的中风风险。为避免将透析患者作为对照组时的选择标准偏差,我们比较了肾移植受者与倾向评分匹配的透析患者的中风风险。
我们使用台湾全民健康保险研究数据库,确定2000年至2009年间新诊断为ESRD的患者。我们将他们分为两组:肾移植组和非肾移植单纯透析组。为评估中风结局,我们使用倾向评分匹配,将每位肾移植患者与未进行肾移植的透析患者进行比较。
共确定了2735例肾移植受者和10940例倾向评分匹配的透析患者。肾移植受者和非肾移植透析患者的总体中风发病率分别为每1000人年9.1例和23.4例。与倾向评分匹配的透析患者相比,接受肾移植的患者总体中风风险、出血性中风和缺血性中风均显著降低,调整后的风险比分别为0.37(95%CI,0.31-0.45)、0.19(95%CI,0.12-0.29)和0.46(95%CI,0.37-0.56)(均P <.001)。
通过倾向评分匹配队列研究,本研究证实,对于新诊断的ESRD患者,肾移植比单纯透析更能降低中风风险。